Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × nintedanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 3 Radiation Pneumonitis 2 Peritoneal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophagogastric Adenocarcinoma 1 Endometrial Adenocarcinoma 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Appendiceal Neoplasms 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡